{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:11:33Z","timestamp":1790223093642,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K20819"],"award-info":[{"award-number":["21K20819"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02787"],"award-info":[{"award-number":["21H02787"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19J22790"],"award-info":[{"award-number":["19J22790"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K19622"],"award-info":[{"award-number":["17K19622"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jconrel.2025.02.064","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:57:04Z","timestamp":1740221824000},"page":"1152-1163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs"],"prefix":"10.1016","volume":"380","author":[{"given":"Akari","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erike Widyasari","family":"Sukowati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jconrel.2025.02.064_bb0005","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/ijgc-00009577-200607000-00001","article-title":"Gynecological cancers in developing countries: the challenge of chemotherapy in low-resources setting","volume":"16","author":"Basile","year":"2006","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41419-020-03335-7","article-title":"Gefitinib initiates sterile inflammation by promoting IL-1\u03b2 and HMGB1 release via two distinct mechanisms","volume":"12","author":"Noguchi","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0015","first-page":"1","article-title":"Macromolecule-drug conjugates in targeted cancer chemotherapy","volume":"1","author":"Sezaki","year":"1984","journal-title":"CRC Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0020","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0025","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gabizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0040","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs","volume":"12","author":"Matsumura","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0045","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-319-16555-4_9","article-title":"Exploring the tumor microenvironment with nanoparticles","volume":"166","author":"Miao","year":"2015","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jconrel.2016.04.028","article-title":"Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin","volume":"232","author":"Petersen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/oxfordjournals.annonc.a010600","article-title":"A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer","volume":"7","author":"Rothenberg","year":"1996","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0060","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"Forbes","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0065","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrmicro.2017.172","article-title":"Engineering bacteria for diagnostic and therapeutic applications","volume":"16","author":"Riglar","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0070","first-page":"4537","article-title":"Tumor-targeted Salmonella as a novel anticancer vector","volume":"57","author":"Pawelek","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0075","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/1751-7915.12787","article-title":"Tumour-targeting bacteria-based cancer therapies for increased specificity and improved outcome","volume":"10","author":"Felgner","year":"2017","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0080","article-title":"The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases","volume":"3\u201311","author":"Coley","year":"1991","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aak9537","article-title":"Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin","volume":"9","author":"Zheng","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0090","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1086\/315497","article-title":"Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium","volume":"181","author":"Clairmont","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0095","article-title":"Therapeutic efficacy of tumor-targeting Salmonella typhimurium A1-R on human colorectal cancer liver metastasis in orthotopic nude-mouse models","volume":"6","author":"Murakami","year":"2015"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0100","first-page":"4331","article-title":"Cancer-cell killing by engineered Salmonella imaged by multiphoton tomography in live mice","volume":"32","author":"Uchugonova","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18388\/abp.2013_1984","article-title":"Salmonella and cancer: from pathogens to therapeutics","volume":"60","author":"Chorobik","year":"2013","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0110","doi-asserted-by":"crossref","first-page":"22605","DOI":"10.18632\/oncotarget.8027","article-title":"Therapy of solid tumors using probiotic Symbioflor-2-restraints and potential","volume":"7","author":"Kocijancic","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0115","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jmb.2005.10.076","article-title":"Environmentally controlled invasion of cancer cells by engineered bacteria","volume":"355","author":"Anderson","year":"2006","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/mt.2009.295","article-title":"Inhibition of tumor growth and metastasis by a combination of escherichia coli-mediated cytolytic therapy and radiotherapy","volume":"18","author":"Jiang","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0125","first-page":"7603","article-title":"Escherichia coli nissle 1917 Targets And Restrains Mouse B16 melanoma and 4T1 breast tumors through expression of Azurin","volume":"78","author":"Zhang","year":"2012"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0130","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/sj.gt.3301499","article-title":"Radio-responsive recA promoter significantly increases TNF\u03b1 production in recombinant clostridia after 2 Gy irradiation","volume":"8","author":"Nuyts","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0135","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.gt.3301659","article-title":"Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia\/necrosis","volume":"9","author":"Liu","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0140","doi-asserted-by":"crossref","first-page":"15155","DOI":"10.1073\/pnas.251543698","article-title":"Combination bacteriolytic therapy for the treatment of experimental tumors","volume":"98","author":"Dang","year":"2001","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0145","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1200\/JCO.2002.20.1.142","article-title":"Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma","volume":"20","author":"Toso","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00002371-200303000-00011","article-title":"Continuous intravenous Administration of Live Genetically Modified Salmonella Typhimurium in patients with metastatic melanoma","volume":"26","author":"Heimann","year":"2003","journal-title":"J. Immunother."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0155","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cgt.7700634","article-title":"Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients","volume":"10","author":"Nemunaitis","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0160","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/1061186X.2022.2122477","article-title":"Impact of tumoral structure and bacterial species on growth and biodistribution of live bacterial therapeutics in xenografted tumours","volume":"31","author":"Takahashi","year":"2023","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/5205","article-title":"Lipid a mutant Salmonella with suppressed virulence and TNF \u03b1 induction retain tumor-targeting in vivo","volume":"17","author":"Low","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119950","article-title":"Biosorption-based 64Cu-labeling of bacteria for pharmacokinetic positron-emission tomography","volume":"590","author":"Nomura","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0175","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nucmedbio.2009.02.004","article-title":"[186Re]liposomal doxorubicin (Doxil): in vitro stability, pharmacokinetics, imaging and biodistribution in a head and neck squamous cell carcinoma xenograft model","volume":"36","author":"Soundararajan","year":"2009","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1349-7006.2008.01003.x","article-title":"Comparison of the effects of the kinase inhibitors imatinib, sorafenib, and transforming growth factor-\u03b2 receptor inhibitor on extravasation of nanoparticles from neovasculature","volume":"100","author":"Kano","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0185","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0190","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1248\/bpb.35.761","article-title":"Pericyte-coverage of human tumor vasculature and nanoparticle permeability","volume":"35","author":"Zhang","year":"2012","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0195","first-page":"2069","article-title":"Digesting a path forward \u2013 the utility of collagenase tumor treatment for improved drug delivery","volume":"15","author":"Dolor","year":"2019"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-019-2058-1","article-title":"The role of collagen in cancer: from bench to bedside","volume":"17","author":"Xu","year":"2019","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0205","first-page":"93","article-title":"Exploring the tumor microenvironment with nanoparticles","volume":"166","author":"Miao","year":"2015","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006692","article-title":"Tumor invasion of Salmonella enterica serovar typhimurium is accompanied by strong hemorrhage promoted by TNF-\u03b1","volume":"4","author":"Leschner","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0215","first-page":"5188","article-title":"Sparse initial entrapment of systemically injected Salmonella typhimurium leads to heterogeneous accumulation within tumors","volume":"63","author":"Forbes","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jare.2023.09.003","article-title":"AI-2 quorum sensing controlled delivery of cytolysin-a by tryptophan auxotrophic low-endotoxic Salmonella and its anticancer effects in CT26 mice with colon cancer","volume":"61","author":"Aganja","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0225","doi-asserted-by":"crossref","first-page":"840","DOI":"10.4161\/cbt.4.8.1891","article-title":"Enhanced therapeutic effect by combination of tumor-targeting Salmonella and endostatin in murine melanoma model","volume":"4","author":"Jia","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0168-3659(97)00261-7","article-title":"Development of liposomal anthracyclines: from basics to clinical applications","volume":"53","author":"Gabizon","year":"1998","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0235","first-page":"987","article-title":"Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes","volume":"54","author":"Gbizon","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0240","article-title":"Attenuated mutants of Salmonella enterica typhimurium mediate melanoma regression via an immune response","volume":"249","author":"Jorge","year":"2024","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112892","article-title":"Delivery of SiRNA-PD-L1 by attenuated Salmonella in combination with oxaliplatin in a hepatocellular carcinoma mouse model","volume":"141","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0250","first-page":"843","article-title":"Attenuated Salmonella enterica typhimurium reduces tumor burden in an autochthonous breast cancer model","volume":"35","author":"Drees","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0255","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ymthe.2005.01.008","article-title":"Systemic administration of attenuated Salmonella choleraesuis in combination with cisplatin for cancer therapy","volume":"11","author":"Lee","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2025.02.064_bb0260","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ijc.22688","article-title":"Tumor-targeting Salmonella typhimurium improves cyclophosphamide chemotherapy at maximum tolerated dose and low-dose metronomic regimens in a murine melanoma model","volume":"121","author":"Jia","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0265","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1126\/science.1130651","article-title":"A bacterial protein enhances the release and efficacy of liposomal cancer drugs","volume":"314","author":"Cheong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.02.064_bb0270","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202313389","article-title":"Engineered microorganisms for advancing tumor therapy","volume":"36","author":"Jia","year":"2024","journal-title":"Adv. Mater."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925001774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T17:52:00Z","timestamp":1770141120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":54,"alternative-id":["S0168365925001774"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.064","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-stromal opening via S. typhimurium VNP20009 administration for complete inhibition of refractory tumor growth with liposomal anticancer drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.02.064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}